Legend Biotech Corp Deferred Tax Relating To Items Charged Or Credited Directly To Equity
Legend Biotech Corp (LEGN) reported Deferred Tax Relating To Items Charged Or Credited Directly To Equity of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2026-03-10
| Period end | Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month | Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-10 | |
| 2024-12-31 | $0.00 20-F · filed 2026-03-10 | |
| 2023-12-31 | $0.00 20-F · filed 2026-03-10 | |
| 2022-12-31 | $0.00 20-F · filed 2025-03-11 | |
| 2021-12-31 | -$4.24M 20-F · filed 2024-03-19 | |
| 2020-12-31 | -$37.75M 20-F · filed 2023-03-30 | |
| 2019-12-31 | -$18.01M 20-F/A · filed 2023-02-17 | $68.92M 20-F · filed 2021-04-02 |
| 2018-12-31 | -$64.06M 20-F · filed 2021-04-02 |